We further showed that the presence of ERCC1+CTCs after chemotherapy correlated with post-therapeutic outcome of ovarian cancer and, particularly, dynamics of ERCC1+CTCs mirrored response to platinum-based chemotherapy. Here, ERCC1 is linked to ovarian carcinoma.